Germline Aberrations in Pancreatic Cancer: Implications for Clinical Care

Germline Aberrations in Pancreatic Cancer: Implications for Clinical Care

Pancreatic ductal adenocarcinoma (PDAC) has an extremely poor prognosis and represents a major public health issue, as both its incidence and mortality are expecting to increase steeply over the next years. Effective screening strategies are lacking, and most patients are diagnosed with unresectable...

Full description

Bibliographic Details
Main Authors: Raffaella Casolino, Vincenzo Corbo, Philip Beer, Chang-il Hwang, Salvatore Paiella, Valentina Silvestri, Laura Ottini, Andrew V. Biankin
Format: Article
Language:English
Published: MDPI AG 2022-06-01
Series:Cancers
Subjects:
germline
pancreatic cancer
BRCA
PARP inhibitors
precision prevention
familial pancreatic cancer
Online Access:https://www.mdpi.com/2072-6694/14/13/3239

Internet

https://www.mdpi.com/2072-6694/14/13/3239

Similar Items